Current Report Filing (8-k)
May 28 2014 - 7:51AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 28, 2014
|
Venaxis, Inc. |
|
(Exact name of Registrant as specified in its charter) |
Colorado
|
|
001-33675
|
|
84-1553387
|
(State or other jurisdiction of incorporation or organization)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
1585 South Perry Street
Castle Rock, Colorado
|
|
80104
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code:
|
|
(303) 794-2000
|
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
The Company’s PowerPoint presentation, furnished as Exhibit 99.1 to this Form 8-K will be used for the first time at the 11th Annual Craig-Hallum Institutional Investor Conference on May 28, 2014. The PowerPoint presentation is also available on the Company’s website.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibits
99.1
|
Venaxis, Inc. information — “Investor Power Point Presentation” dated May 28, 2014.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
Venaxis, Inc.
(Registrant)
|
|
May 28, 2014
|
By:
|
/s/ Jeffrey G. McGonegal
|
|
|
|
Name:
|
Jeffrey G. McGonegal
|
|
|
|
Title:
|
Chief Financial Officer
|
|
|
Exhibit 99.1
Bioptix, Inc. (NASDAQ:BIOP)
Historical Stock Chart
From Apr 2024 to May 2024
Bioptix, Inc. (NASDAQ:BIOP)
Historical Stock Chart
From May 2023 to May 2024